Movement Alert|Encompass Health Corporation Intraday Rise 6.46% in Regular Trading, Q3 Earnings Beat and Full-Year Guidance Raised

Market Focus10-30

On October 30, Encompass Health Corporation rose 6.46% in Regular Trading, trading at $130.215 per share, with turnover of $134 million.

The move followed the company’s latest quarterly results, which exceeded Wall Street expectations, alongside an increase in full-year guidance and a higher analyst price target.

For the third quarter, adjusted EPS was $1.52 versus the $1.36 consensus and $1.23 a year earlier, while revenue rose to $1.609 billion from $1.48 billion, slightly above the $1.601 billion expectation. The company lifted full-year adjusted EPS guidance to $6.23-$6.37 from $6.02-$6.25 and projected revenue of $6.45 billion-$6.50 billion, compared with prior guidance of $6.41 billion-$6.49 billion. Separately, BofA Securities raised its price target to $157 from $153.

(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment